A role for BCL2L13 and autophagy in germline purifying selection of mtDNA
Mammalian mitochondrial DNA (mtDNA) is inherited uniparentally through the female germline without undergoing recombination. This poses a major problem as deleterious mtDNA mutations must be eliminated to avoid a mutational meltdown over generations. At least two mechanisms that can decrease the mut...
Saved in:
Published in | PLoS genetics Vol. 19; no. 1; p. e1010573 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
06.01.2023
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Mammalian mitochondrial DNA (mtDNA) is inherited uniparentally through the female germline without undergoing recombination. This poses a major problem as deleterious mtDNA mutations must be eliminated to avoid a mutational meltdown over generations. At least two mechanisms that can decrease the mutation load during maternal transmission are operational: a stochastic bottleneck for mtDNA transmission from mother to child, and a directed purifying selection against transmission of deleterious mtDNA mutations. However, the molecular mechanisms controlling these processes remain unknown. In this study, we systematically tested whether decreased autophagy contributes to purifying selection by crossing the C5024T mouse model harbouring a single pathogenic heteroplasmic mutation in the tRNA
Ala
gene of the mtDNA with different autophagy-deficient mouse models, including knockouts of
Parkin
,
Bcl2l13
,
Ulk1
, and
Ulk2
. Our study reveals a statistically robust effect of knockout of
Bcl2l13
on the selection process, and weaker evidence for the effect of
Ulk1
and potentially
Ulk2
, while no statistically significant impact is seen for knockout of
Parkin
. This points at distinctive roles of these players in germline purifying selection. Overall, our approach provides a framework for investigating the roles of other important factors involved in the enigmatic process of purifying selection and guides further investigations for the role of BCL2L13 in the elimination of non-synonymous mutations in protein-coding genes. |
---|---|
Bibliography: | new_version ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 I have read the journal’s policy and the authors of this manuscript have the following competing interests: N.G.L. is inventor of the C5024T mutant mouse licensed to the pharmaceutical industry by the Max Planck Society. N.G.L. is a scientific founder and holds stock in Pretzel Therapeutics Inc. The other authors have no competing interests. |
ISSN: | 1553-7404 1553-7390 1553-7404 |
DOI: | 10.1371/journal.pgen.1010573 |